91 |
Modeling premalignant lung squamous carcinoma via gene expression changes associated with EP300 knockoutFu, Dany 14 June 2023 (has links)
Lung cancer is the third most common type of cancer and the leading cause of cancer death, in both men and women, and prognosis for lung carcinoma remains poor due to late diagnosis. While lung squamous cell carcinoma (LUSC) makes up 20-30% of all lung cancer cases, identification of genetic signatures and successful targeted therapies remain limited. An ongoing effort is being made to create an in vitro system for modeling the early stages of lung squamous carcinoma and premalignancy, which will ultimately serve as a model for drug discovery. A previous effort performed whole exome and targeted DNA sequencing to reveal the somatic mutations in endobronchial biopsies that harbored lung squamous premalignant histology. EP300 was identified as a candidate gene which may act as a driver for carcinogenesis, but remains understudied when compared to prominent oncogenic driver genes such TP53, NOTCH1, or NFE2L2 in LUSC. The p300 protein is a histone acetyltransferase that regulates gene expression by means of chromatin remodeling and has been implicated in various diseases, including cancer. My objective as part of my thesis was to first generate stable EP300 knockout (KO) clones from the NL20 bronchial epithelial cell line utilizing the CRISPR/Cas gene editing system. Using the NL20 clones and EP300 KO clones in the HBEC-3KT cell line generated in a previous effort, I then validated the knockouts at the DNA, RNA, and protein levels. Literature review was also conducted to identify possible cellular pathways that EP300 participates in and validate its role in those pathways by observing changes in downstream protein targets. Finally, I generated RNA sequencing data from the functionally validated clones to identify differentially expressed genes and cellular pathways perturbed by EP300 knockout. Through these efforts, I developed sets of gene signatures unique to each cell line and found that EP300 is associated with bronchial carcinogenesis progression and likely functions as an oncogene in LUSC.
|
92 |
A Gene Co-Expression Network Mining Approach for Differential Expression AnalysisMorgan, Daniel Colin 14 May 2015 (has links)
No description available.
|
93 |
Computational Approaches for Cancer Precision MedicineStetson, Lindsay C. 03 June 2015 (has links)
No description available.
|
94 |
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING NETWORKSDurmaz, Arda 30 August 2017 (has links)
No description available.
|
95 |
Novel bioinformatics tools for miRNA-Seq analysis, RNA structure visualization, and genome-wide repeat detectionShi, Jieming 19 July 2017 (has links)
No description available.
|
96 |
IDENTIFICATION OF MUTATIONAL LANDSCAPES IN AFRICAN AMERICAN TRIPLE-NEGATIVE BREAST CANCERKaur, Jaspreet 01 June 2018 (has links)
No description available.
|
97 |
Agent Based Model of Biolumiescence in Vibrio fischeriMylavarapu, Omkar Swarup Krupa Sagar January 2008 (has links)
No description available.
|
98 |
Computational approaches to study microRNA networksKaimal, Vivek 19 April 2011 (has links)
No description available.
|
99 |
Nucleic Acid High-Throughput Sequencing Studies Present Unique Challenges in Analysis and InterpretationOman, Kenji 01 October 2015 (has links)
No description available.
|
100 |
A Genomics and Mathematical Modeling Approach for the Study of Helicobacter Pylori associated Gastritis and Gastric CancerMarwaha, Shruti 11 September 2015 (has links)
No description available.
|
Page generated in 0.0875 seconds